BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Head and neck cancer AND MDM2, HDM2, 4193, ENSG00000135679, HDMX, MGC71221, hdm2, Q00987
434 results:

  • 1. Mutational landscape of oral mucosal melanoma based on comprehensive cancer genomic profiling tests in a Japanese cohort.
    Ichimura N; Urata Y; Kobayashi T; Hibi H
    Oral Oncol; 2024 May; 152():106807. PubMed ID: 38615585
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Potential targets of diosgenin for the treatment of oral squamous cell carcinoma and their bioinformatics and transcriptional profiling analyses.
    Xiao Y; Xu B; Li X; Ding T; Zhao W; Nie X; Mu J; Xiao Z; Wang Q; Ren Q; Zhang E
    Steroids; 2024 May; 205():109393. PubMed ID: 38458369
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. PHF5A promotes esophageal squamous cell carcinoma progression via stabilizing VEGFA.
    Chang Z; Jia Y; Gao M; Song L; Zhang W; Zhao R; Yu D; Liu X; Li J; Qin Y
    Biol Direct; 2024 Mar; 19(1):19. PubMed ID: 38429756
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Regulatory and Interacting Partners of PDLIM7 in Thyroid cancer.
    Rood K; Yamauchi CR; Sharma U; Laxa RT; Robins C; Lanza G; Sánchez-Ruiz K; Khan A; Kim HS; Shields A; Kennedy K; Mirshahidi S; Perez MC; Firek A; Munir I; Simental AA; Khan S
    Curr Oncol; 2023 Dec; 30(12):10450-10462. PubMed ID: 38132395
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Giant liposarcoma of esophagus: a rare case report.
    Li Q; Chen S; Li Y; Chen Z; Liu Y; Guo W
    Diagn Pathol; 2023 Sep; 18(1):100. PubMed ID: 37670330
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Comparison of Immunohistochemical Markers in Oral Submucous Fibrosis and Oral Submucous Fibrosis Transformed to Oral Squamous Cell Carcinoma-A Systematic Review and Meta-Analysis.
    Mohapatra D; Panda S; Mohanty N; Panda S; Lewkowicz N; Lapinska B
    Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511530
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Odontogenic Carcinosarcoma: Clinicopathologic and Molecular Features of Three Cases, a Literature Review and Nomenclature Proposal.
    Cole G; Chi A; Cook DR; Kubik M; Bilodeau EA; Seethala RR
    Head Neck Pathol; 2023 Sep; 17(3):751-767. PubMed ID: 37486533
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Association of Interactions between Metabolic 'Caretaker' Genes, p53, mdm2, and Tobacco Use with the Risk of Oral cancer: A Multifactor Dimensionality Reduction Approach.
    Singh RD; Patel KA; Patel JB; Patel PS
    Asian Pac J Cancer Prev; 2023 Apr; 24(4):1231-1237. PubMed ID: 37116145
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Long noncoding RNA LINC01088 inhibits esophageal squamous cell carcinoma progression by targeting the NPM1-hdm2-p53 axis.
    Liang F; Luo Q; Han H; Zhang J; Yang Y; Chen J
    Acta Biochim Biophys Sin (Shanghai); 2023 Mar; 55(3):367-381. PubMed ID: 36942988
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. LIM domain-containing protein Ajuba inhibits chemotherapy-induced apoptosis by negatively regulating p53 stability in colorectal cancer cells.
    Xu B; Li Q; Zhang J; Chen F
    Mol Oncol; 2023 Aug; 17(8):1678-1691. PubMed ID: 36931700
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Genomic Profiling of the Craniofacial Ossifying Fibroma by Next-Generation Sequencing.
    Bahceci DH; Grenert JP; Jordan RCK; Horvai AE
    Head Neck Pathol; 2023 Sep; 17(3):722-730. PubMed ID: 36928741
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Atypical spindle cell/pleomorphic lipomatous tumour (ASPLT): A report of three FNA cases and comparison with spindle cell/pleomorphic lipoma cytopathology.
    Wakely PE
    Cytopathology; 2023 Jul; 34(4):346-352. PubMed ID: 36856555
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. circFNDC3B Accelerates Vasculature Formation and Metastasis in Oral Squamous Cell Carcinoma.
    Li X; Wang C; Zhang H; Li Y; Hou D; Liu D; Xu R; Cheng J; Liu L; Fu Y; Ye J; Jiang H
    Cancer Res; 2023 May; 83(9):1459-1475. PubMed ID: 36811957
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. [A case report of adult primary soft tissue sarcoma of the head and neck].
    Liu L; Qiu H; Hui M; Jiang F; Wang D; Lin Y; Yang X; Yao J
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2023 Feb; 37(2):146-149. PubMed ID: 36756833
    [No Abstract]    [Full Text] [Related]  

  • 15. Bioinformatics analysis of miRNA and its associated genes to identify potential biomarkers of oral submucous fibrosis and oral malignancy.
    Mohanan EM; Jhala D; More CB; Patel AK; Joshi C
    Cancer Rep (Hoboken); 2023 Apr; 6(4):e1787. PubMed ID: 36708238
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Primary head and neck cancer cell cultures are susceptible to proliferation of Epstein-Barr virus infected lymphocytes.
    Shao S; Scholtz LU; Gendreizig S; Martínez-Ruiz L; Florido J; Escames G; Schürmann M; Hain C; Hose L; Mentz A; Schmidt P; Wang M; Goon P; Wehmeier M; Brasch F; Kalinowski J; Oppel F; Sudhoff H
    BMC Cancer; 2023 Jan; 23(1):47. PubMed ID: 36639629
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. head pleomorphic sarcoma showing murine double minute 2 amplification without a well-differentiated liposarcoma component in a pediatric patient.
    Akaihata M; Takahashi I; Kakuda Y; Kawata T; Mukaigawa T; Onitsuka T; Murayama S; Ishida Y
    Cancer Rep (Hoboken); 2023 Feb; 6(2):e1774. PubMed ID: 36572546
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. CEACAM5 inhibits the lymphatic metastasis of head and neck squamous cell carcinoma by regulating epithelial-mesenchymal transition via inhibiting mdm2.
    Wang X; Li Y; Pan M; Lu T; Wang M; Wang Z; Liu C; Hu G
    Clin Sci (Lond); 2022 Nov; 136(22):1691-1710. PubMed ID: 36377775
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Nutlin-3 acts as a DNA methyltransferase inhibitor to sensitize esophageal cancer to chemoradiation.
    Chang WL; Hsieh CH; Kuo IY; Lin CH; Huang YL; Wang YC
    Mol Carcinog; 2023 Feb; 62(2):277-287. PubMed ID: 36342355
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Superficial GLI1-amplified mesenchymal neoplasms: Expanding the spectrum of an emerging entity which reaches the realm of dermatopathology.
    Machado I; Hosler GA; Traves V; Claramunt R; Sanmartín O; Santonja C; Carvajal N; Zazo S; Requena L; Alfonso VS; Domenech EV; Llombart-Bosch A; Bridge JA; Linos K
    J Cutan Pathol; 2023 Jun; 50(6):487-499. PubMed ID: 36316249
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 22.